Chagas Disease Management Market Trends and Segments Forecast To 2030
The report "Chagas Disease Management Market by Treatment Type (Antiparasitic treatment, Symptomatic treatment), by Drug Type (Benznidazole, Nifurtimox), by Distribution Channel (Hospital pharmacies, Retail pharmacies, Online Pharmacies) - Global Forecasts to 2030" The global Chagas Disease Management Market is projected to reach USD 5.72 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 7.6% during the forecast period 2024-2030. The growth of the market is majorly driven by the Increase in non-invasive cancer treatments through radiation therapy. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=15817 Competitive Dashboard: The prominent key players operating in the global Chagas Disease Management Market are AstraZeneca (U.K) Bayer AG (Germany) Daiichi Sankyo Company Ltd (Japan) Eisai Co Ltd (Japan) GlaxoSmithKline Plc. (U.K) Grupo Praxis Pharmaceutical SA (Spain) KaloBios Pharmaceuticals, Inc. (U.S.) Kance...